Quick Answer
SINOVAC BIOTECH LTD reported Gross Profit of $266.75 million for fiscal year 2023.
SINOVAC BIOTECH LTD Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2023 | $266.75M | -67.0% |
| 2022 | $808.30M | -95.6% |
| 2021 | $18.30B | +4027.4% |
| 2020 | $443.44M | +107.6% |
| 2019 | $213.58M | +4.2% |
| 2018 | $204.93M | +33.0% |
| 2017 | $154.11M | +208.0% |
| 2016 | $50.04M | +2.1% |
| 2015 | $49.01M | +3.3% |
| 2014 | $47.46M | -7.4% |
| 2013 | $51.27M | +70.2% |
| 2012 | $30.12M | -15.7% |
| 2011 | $35.71M | +114.1% |
| 2010 | $16.68M | -74.0% |
| 2009 | $64.13M | — |
- SINOVAC BIOTECH LTD showed a decrease of -67.0% in Gross Profit compared to the prior fiscal year.
- Over the 2009–2023 period, SINOVAC BIOTECH LTD’s gross profit has grown by 315.9% (from $64.13 million to $266.75 million).
- The most recent figure is from SINOVAC BIOTECH LTD’s fiscal year 2023 report (Form 20-F), filed with the SEC on April 29, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: